Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Atorvastatin
Atorvastatin calcium trihydrate 10.825mg equivalent to atorvastatin 10mg
Film coated tablet
PSM Healthcare Limited trading as API Consumer Brands
Ind-Swift Limited, Punjab, India
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Atorvastatin
Atorvastatin calcium trihydrate 21.65mg equivalent to atorvastatin 20mg
Film coated tablet
PSM Healthcare Limited trading as API Consumer Brands
Ind-Swift Limited, Punjab, India
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Atorvastatin
Atorvastatin calcium trihydrate 43.3mg equivalent to atorvastatin 40mg
Film coated tablet
PSM Healthcare Limited trading as API Consumer Brands
Ind-Swift Limited, Punjab, India
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Atorvastatin
Atorvastatin calcium trihydrate 86.6mg equivalent to atorvastatin 80mg
Film coated tablet
PSM Healthcare Limited trading as API Consumer Brands
Ind-Swift Limited, Punjab, India
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Loniten
Minoxidil 10mg
Tablet
Pfizer New Zealand Limited
Patheon Inc, Whitby, Canada
|
Dated this 20th day of January 2017.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).
Gazette.govt.nz